SCHEMBL8102798

SCHEMBL8102798

CCn1c(O)cc(=O)c(O)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
KDM4E B2RXH2 8/20 0.41
KDM6A O15550 1/20 0.38
KDM4A O75164 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM5C P41229 1/20 0.38
KDM2B Q8NHM5 1/20 0.38
DOHH Q9BU89 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TP53 P04637 1/20 0.38
CYP2D6 P10635 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SRC P12931 2/20 0.37
LMNA P02545 1/20 0.37
COMT P21964 2/20 0.36
TYR P14679 1/20 0.33
RCE1 Q9Y256 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7546969 0.72 POLB (0.49) POLBKDM4EL3MBTL1SRCLMNA
Hydrochloric Acid SCHEMBL6993015 0.71 POLB (0.47) POLBKDM4EL3MBTL1SRCLMNA
SCHEMBL4050261 0.69 POLB (0.55) POLBKDM4EL3MBTL1HTTSRC
SCHEMBL13555550 0.68 POLB (0.45) POLBKDM4ECYP2C19L3MBTL1HTT
SCHEMBL11228235 0.68 KDM4E (0.45) POLBKDM4ECYP2C19L3MBTL1HTT
SCHEMBL5525055 0.68 KDM4E (0.62) KDM4EKDM6AKDM4ACYP2C9CYP2C19
Hydrochloric Acid SCHEMBL6992862 0.67 POLB (0.47) POLBKDM4ESRCLMNATYR
SCHEMBL9478763 0.67 MAPT (0.51) POLBKDM4EKDM6AKDM4ACYP2C9
SCHEMBL11556558 0.66 GPR35 (0.37) POLBKDM4EL3MBTL1SRCALDH1A1
SCHEMBL24635877 0.66 KDM4E (0.43) KDM4EKDM6AKDM4ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36831-E TREATMENT OF IRON DEFICIENCY ANEMIA BRITISH TECHNOLOGY GROUP LTD. (GB) 2000-08-22 US disclosed
US-RE35948-E TREATING TOXIC METAL CONCENTRATION BY ADMINISTERING N-SUBSTITUTED 3-HYDROXYPYRID-2-ONE OR 3-HYDROXYPYRID-4-ONE BRITISH TECHNOLOGY GROUP LTD. (GB) 1998-11-03 US disclosed
EP-0305646-B1 3-Hydroxypyrid-4-ones and pharmaceutical compositions BRITISH TECH GROUP (GB) 1996-11-13 EP disclosed
EP-0305646-A2 3-Hydroxypyrid-4-ones and pharmaceutical compositions BTG INTERNATIONAL LIMITED (GB) 1989-03-08 EP disclosed
US-4650793-A NITROGEN-SUBSTITUTED NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-03-17 US disclosed
US-4585780-A CHELATION OF HEAVY METALS IN BLOOD NATIONAL RESEARCH DEVELOPMENT CORP. (GB) 1986-04-29 US disclosed
EP-0120669-A2 Hydroxypyridones, and their pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-10-03 EP disclosed
EP-0120670-A1 Iron III complexes of hydroxypyridones, and their pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-10-03 EP disclosed